GO:0036211 protein modification process: Mechanisms, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0036211 (protein modification process) describes the covalent alteration of amino acids in proteins, peptides, and nascent polypeptides, including co-translational and post-translational modifications.
• Protein modification encompasses diverse chemical changes such as phosphorylation, glycosylation, SUMOylation, palmitoylation, and cysteine-based modifications, each with distinct regulatory roles [2,3,4,7,8].
• These modifications control protein stability, localization, activity, and interactions, and are central to processes like autophagy, apoptosis, and ferroptosis [1,5,7].
• Dysregulation of protein modification is implicated in cardiovascular disease, cancer, neurodegeneration, and metabolic disorders [3,4,7].
• Key enzymes and substrates include SUMO proteins, glycosyltransferases, palmitoyltransferases, and autophagy-related proteins [3,4,5,7].
• CRISPR-based knockout, knock-in, and point-mutation models enable precise functional dissection of protein modification pathways in disease research [1,5].
Description
Protein modification is a fundamental biological process that expands the functional repertoire of the proteome beyond what is encoded by the genome. The Gene Ontology term GO:0036211, protein modification process, captures the covalent alteration of one or more amino acids in proteins, peptides, and nascent polypeptides, including co-translational and post-translational modifications. This process is essential for virtually all cellular activities, from signal transduction and gene expression to cell cycle progression and stress responses. Researchers study protein modification to understand how cells dynamically regulate protein function and how disruptions contribute to human disease [3,4,7]. The breadth of modifications, including phosphorylation, glycosylation, SUMOylation, palmitoylation, and cysteine-based chemistry, underscores the complexity and importance of this ontology term [2,3,4,7,8]. Advances in mass spectrometry, CRISPR screening, and bioinformatics have accelerated the discovery of new modification events and their regulatory roles in health and disease [1,5,6].
protein modification process At A Glance
| GO ID | GO:0036211 |
|---|---|
| GO term | protein modification process |
| Ontology | biological_process |
| Synonym | cellular protein modification process, process resulting in protein modification, protein modification |
| Major function | Covalent alteration of amino acids in proteins, peptides, and nascent polypeptides, including co- and post-translational modifications |
| Substrate range | Proteins, peptides, nascent polypeptides, and charged tRNAs |
| Modification types | Phosphorylation, glycosylation, SUMOylation, palmitoylation, cysteine modification, and others |
| Biological impact | Regulates protein stability, activity, localization, interactions, and cellular signaling |
What Is GO:0036211?
GO:0036211, protein modification process, is defined as the covalent alteration of one or more amino acids occurring in proteins, peptides, and nascent polypeptides, including co-translational and post-translational modifications. It also includes the modification of charged tRNAs that are destined to occur in a protein, representing a pre-translation modification. This term encompasses a wide range of chemical changes such as phosphorylation, glycosylation, SUMOylation, palmitoylation, and many others that alter protein properties and functions.
Why Is protein modification process Important in Cell Biology?
Protein modification is a central mechanism by which cells adapt to changing environments and maintain homeostasis [2,6]. It controls nearly every aspect of protein function, from enzymatic activity and subcellular localization to protein-protein interactions and degradation [3,5]. Dysregulation of protein modification pathways is linked to a wide range of diseases, including cardiovascular disorders, cancer, neurodegeneration, and metabolic syndromes [3,4,7]. Understanding these modifications provides critical insights into disease mechanisms and identifies potential therapeutic targets [1,5,7].
• Regulates protein stability, activity, and interactions, influencing virtually all cellular processes.
• Controls key signaling pathways such as autophagy, apoptosis, and ferroptosis [1,5,7].
• SUMOylation modulates transcription, DNA repair, and stress responses, with implications in cancer and neurodegeneration.
• Glycosylation affects protein folding, cell adhesion, and immune recognition, and is linked to cardiovascular disease.
• Palmitoylation regulates membrane association and apoptotic signaling.
• Cysteine-based chemical modifications are exploited for targeted protein engineering and drug development.
• Dysregulation of protein modification contributes to cancer, diabetes, and neurodegenerative disorders [3,4,7].
• Protein modification enzymes are promising drug targets, and modification profiles serve as biomarkers [1,5].
• CRISPR-based screens enable systematic discovery of modification regulators and their disease relevance [1,5].
What Happens During protein modification process?
Co-translational and Post-translational Modifications
In simple terms: Proteins can be chemically changed while they are being made or after they are fully synthesized.
Protein modification occurs co-translationally, as nascent polypeptides emerge from the ribosome, and post-translationally, after protein synthesis is complete. These modifications include the addition of chemical groups such as phosphate, sugar, SUMO, or lipid moieties, as well as cleavage events [2,3,4,7]. Co-translational modifications like N-linked glycosylation influence protein folding and stability, while post-translational modifications such as phosphorylation and SUMOylation dynamically regulate protein function in response to cellular signals [2,3,4].
Major Types of Protein Modifications
In simple terms: There are many different chemical tags that can be attached to proteins, each with specific effects.
Major protein modifications include phosphorylation, glycosylation, SUMOylation, palmitoylation, acetylation, methylation, and ubiquitination-like processes [2,3,4,7]. Glycosylation involves the attachment of carbohydrate chains and is critical for protein folding, stability, and cell-cell recognition. SUMOylation attaches small ubiquitin-like modifier (SUMO) proteins to lysine residues, regulating transcription, DNA repair, and stress responses. Palmitoylation adds fatty acid chains, promoting membrane association and affecting apoptotic signaling. Cysteine-based modifications, including disulfide formation and chemical tagging, are widely used in protein engineering.
Enzymatic Machinery and Substrate Recognition
In simple terms: Specific enzymes recognize target proteins and attach or remove chemical groups.
Protein modification is catalyzed by dedicated enzymes such as kinases, glycosyltransferases, SUMO-conjugating enzymes (E1, E2, E3 ligases), and palmitoyltransferases [3,4,7]. These enzymes recognize consensus sequences or structural features in substrate proteins, ensuring specificity [3,4]. For example, SUMOylation requires a cascade of E1 activating enzyme (SAE1/SAE2), E2 conjugating enzyme (UBC9), and E3 ligases that confer substrate specificity. Glycosyltransferases transfer sugar moieties to specific amino acids, while palmitoyl acyltransferases (PATs) catalyze thioester linkage of palmitate to cysteine residues [4,7].
Reversibility and Regulatory Dynamics
In simple terms: Most modifications can be removed by other enzymes, making the process reversible and dynamic.
Protein modifications are often reversible, allowing dynamic regulation of protein function [2,3]. For instance, phosphorylation is reversed by phosphatases, SUMOylation by SENP proteases, and palmitoylation by depalmitoylases [3,7]. This reversibility enables rapid cellular responses to stimuli and is essential for processes such as cell cycle progression, signal transduction, and stress adaptation [2,3]. The balance between modifying and demodifying enzymes determines the net modification state of a protein [3,7].
Functional Consequences of Protein Modification
In simple terms: Adding or removing chemical groups changes how a protein behaves in the cell.
Protein modifications alter protein conformation, activity, stability, localization, and interactions with other molecules [2,3,5]. For example, SUMOylation can modulate transcription factor activity and protein-protein interactions. Glycosylation affects protein trafficking and cell surface recognition. Palmitoylation promotes membrane anchoring and influences apoptotic pathways. These functional consequences are central to autophagy, apoptosis, ferroptosis, and many other cellular processes [1,5,7].
Key Genes Involved in GO:0036211 protein modification process
The following genes and proteins are key players in protein modification processes, including enzymes, substrates, and regulatory factors.
| Gene | Major Role | Research Relevance |
|---|---|---|
| SUMO1 | Small ubiquitin-like modifier; conjugated to target proteins | Regulates transcription, DNA repair, and stress responses; implicated in cancer and neurodegeneration |
| UBC9 (UBE2I) | E2 SUMO-conjugating enzyme | Essential for SUMOylation; knockout is lethal in many organisms |
| SAE1 | SUMO E1 activating enzyme subunit | Required for SUMOylation cascade; target for cancer therapy |
| SAE2 (UBA2) | SUMO E1 activating enzyme subunit | Required for SUMOylation; potential drug target |
| SENP1 | SUMO-specific protease | Reverses SUMOylation; regulates gene expression and cell cycle |
| OGT | O-GlcNAc transferase; adds O-GlcNAc to serine/threonine | Regulates signaling, metabolism, and cardiovascular function |
| OGA | O-GlcNAcase; removes O-GlcNAc | Balances O-GlcNAcylation; linked to diabetes and neurodegeneration |
| ZDHHC2 | Palmitoyl acyltransferase | Palmitoylates proteins; regulates apoptosis and cancer |
| ZDHHC7 | Palmitoyl acyltransferase | Palmitoylates signaling proteins; affects cell growth |
| APT1 (LYPLA1) | Depalmitoylase | Removes palmitate; regulates protein trafficking |
| ATG5 | Autophagy-related protein; conjugated to ATG12 | Essential for autophagy; modification required for autophagosome formation |
| ATG12 | Ubiquitin-like protein; conjugated to ATG5 | Autophagy activation; modification process critical for function |
| ATG7 | E1-like enzyme for ATG12 and ATG8 | Required for autophagy; knockout blocks autophagy |
| LC3 (MAP1LC3B) | Ubiquitin-like protein; conjugated to phosphatidylethanolamine | Autophagosome marker; lipidation is a protein modification |
| GPX4 | Glutathione peroxidase 4; undergoes modification in ferroptosis | Protects against lipid peroxidation; modification affects ferroptosis |
| NCOA4 | Nuclear receptor coactivator 4; regulates ferritinophagy | Modification and degradation in ferroptosis |
| Cysteine proteases (e.g., CASP3) | Cysteine-dependent proteases | Cysteine modification affects apoptosis and drug targeting |
How Is protein modification process Regulated?
Protein modification processes are tightly regulated at multiple levels. The expression and activity of modifying enzymes (e.g., kinases, SUMO ligases, glycosyltransferases) are controlled by transcription, post-translational modifications, and subcellular localization [3,4,7]. Reversibility is ensured by demodifying enzymes such as phosphatases, SENPs, and depalmitoylases, which counterbalance modification [3,7]. Signaling pathways including mTOR, AMPK, and stress-responsive kinases modulate modification machinery in response to nutrient status, energy stress, and environmental cues [1,5]. For example, autophagy-related protein modifications are regulated by nutrient-sensing pathways, and ferroptosis involves modification-dependent degradation of GPX4 and NCOA4 [1,5]. Additionally, crosstalk between different modifications (e.g., phosphorylation and SUMOylation) fine-tunes protein function.
protein modification process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| SUMO1 | Cancer, neurodegeneration | Knockout and knock-in cell lines; SUMOylation assays |
| OGT | Cardiovascular disease, diabetes | Point-mutation models to alter catalytic activity; O-GlcNAc profiling |
| ZDHHC2 | Cancer, apoptosis | Knockout and overexpression models; palmitoylation assays |
| ATG5 | Autophagy-related diseases, cancer | Knockout models to block autophagy; ATG5-ATG12 conjugation assays |
| GPX4 | Ferroptosis, cancer | Point mutations to modulate activity; ferroptosis induction models |
Protein Modification in Cancer
Dysregulated protein modification is a hallmark of cancer. SUMOylation controls the activity of oncogenes and tumor suppressors, and altered SUMO pathway components are observed in various cancers. Glycosylation changes promote tumor cell invasion and immune evasion. Palmitoylation regulates oncogenic signaling and apoptosis resistance. Targeting modification enzymes, such as SUMO E1 or palmitoyltransferases, is an emerging therapeutic strategy [3,7].
Protein Modification in Cardiovascular Disease
Glycosylation, particularly O-GlcNAcylation, plays a critical role in cardiovascular health and disease. Altered O-GlcNAc cycling contributes to diabetic cardiomyopathy, heart failure, and vascular dysfunction. SUMOylation also protects against cardiac ischemia-reperfusion injury by modulating stress responses. These modifications represent potential biomarkers and therapeutic targets in cardiovascular medicine.
Protein Modification in Neurodegeneration
Defective protein modification is implicated in neurodegenerative disorders such as Alzheimer's and Parkinson's diseases. SUMOylation regulates protein aggregation and neuronal survival. Palmitoylation affects synaptic function and protein trafficking, and its dysregulation is linked to neurodegeneration. Glycosylation defects impair lysosomal function and contribute to lysosomal storage disorders.
Protein Modification in Ferroptosis and Autophagy
Protein modification and degradation are central to ferroptosis, an iron-dependent form of cell death. Modifications of GPX4 and NCOA4 regulate lipid peroxidation and ferritinophagy. Autophagy activation requires the conjugation of ATG12 to ATG5 and LC3 lipidation, both protein modification events. Targeting these pathways offers new avenues for cancer therapy and neurodegeneration research [1,5].
From protein modification process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does a gene regulate a specific protein modification? | CRISPR knockout cell lines followed by modification-specific assays [1,5] |
| How does a point mutation in a modification enzyme affect substrate specificity? | CRISPR point-mutation knock-in models [3,4] |
| What is the effect of tagging a modification substrate on its localization? | Knock-in of fluorescent or epitope tags |
| Can overexpression of a modifying enzyme drive disease phenotypes? | Doxycycline-inducible overexpression cell lines |
| Which genes are essential for a modification pathway? | Genome-wide CRISPR knockout library screening [1,5] |
| How do modifications change under drug treatment? | Quantitative proteomics with isobaric labeling [1,4] |
How to Study the protein modification process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| LC-MS/MS proteomics | Identification and quantification of modified peptides | Mapping modification sites and stoichiometry [2,3,4] |
| CRISPR knockout screening | Gene essentiality for a modification phenotype | Discovering regulators of ferroptosis or autophagy [1,5] |
| Western blot with modification-specific antibodies | Presence and level of a specific modification | Validating SUMOylation, glycosylation, or palmitoylation [3,4,7] |
| Immunoprecipitation | Protein-protein interactions and modified protein complexes | Isolating SUMOylated or palmitoylated proteins [3,7] |
| Click chemistry | Detection of alkyne- or azide-tagged modifications | Labeling palmitoylated or glycosylated proteins [7,8] |
| FRET biosensors | Real-time modification dynamics in live cells | Monitoring phosphorylation or SUMOylation |
| RNA-seq | Transcriptional changes upon modification perturbation | Assessing downstream effects of knockout [1,5] |
| Bioinformatics pathway analysis | Enrichment of modification-related gene sets | Interpreting omics data in disease contexts [1,5] |
Mass Spectrometry-Based Proteomics
Mass spectrometry is a powerful method to identify and quantify protein modifications. Enrichment strategies for phosphorylated, glycosylated, SUMOylated, or palmitoylated peptides coupled with LC-MS/MS enable site-specific mapping [2,3,4,7]. Quantitative proteomics using SILAC or TMT allows comparison of modification states across conditions [1,4].
CRISPR Screening and Functional Genomics
Genome-wide CRISPR knockout or activation screens can identify genes that regulate specific protein modifications. For example, screens for ferroptosis regulators have uncovered modification enzymes. Libraries targeting modification-related genes enable systematic discovery of pathway components.
Biochemical and Immunological Assays
Western blotting with modification-specific antibodies, immunoprecipitation, and in vitro modification assays are standard for validating modification events [3,5,7]. For SUMOylation, His-tagged SUMO pull-downs are common. Palmitoylation can be assessed by acyl-biotin exchange or click chemistry.
Imaging and Live-Cell Analysis
Fluorescently tagged proteins and modification-specific biosensors allow real-time visualization of modification dynamics in live cells [5,7]. FRET-based sensors for phosphorylation or SUMOylation provide spatial and temporal resolution.
How CRISPR Can Be Used to Study GO:0036211 protein modification process
Knockout
CRISPR knockout of genes encoding modification enzymes or substrates is used to determine their necessity in specific pathways. For example, knocking out ATG5 or ATG7 blocks autophagy, while GPX4 knockout induces ferroptosis [1,5]. Knockout cell lines are valuable for validating modification-dependent phenotypes and identifying compensatory mechanisms [1,5].
Point Mutation
CRISPR point mutation introduces precise amino acid substitutions to dissect catalytic activity or modification sites. For instance, mutating the catalytic cysteine of a palmitoyltransferase or the SUMO acceptor lysine in a substrate can reveal functional consequences [3,4,7]. Point-mutation models are essential for separating modification events from other protein functions [3,4].
Knock-in
Knock-in of tags (e.g., GFP, HA, or biotin ligase) into endogenous loci enables tracking of modified proteins and their interactomes. Tagged knock-in of LC3 or ATG5 allows visualization of autophagosomes and modification dynamics. Knock-in of disease-associated mutations in modification enzymes can model human disorders [3,4].
Overexpression
Overexpression of modifying enzymes or substrates via CRISPR activation or cDNA delivery can drive pathway activation and reveal gain-of-function phenotypes. For example, overexpressing SUMO1 or palmitoyltransferases can enhance modification levels and affect cell survival [3,7]. Inducible overexpression systems provide temporal control.
How EDITGENE Supports protein modification process Research
Researchers studying protein modification process-related genes often need to determine whether a candidate gene is causally involved in a specific modification pathway, disease phenotype, or drug response. Precise genetic models are essential to move from correlation to causation. EDITGENE provides a comprehensive suite of CRISPR-based services tailored to protein modification research, enabling rigorous functional validation.
Contact EDITGENE today to design your custom CRISPR model for protein modification process research.
Frequently Asked Questions About protein modification process
What is protein modification process GO:0036211?
GO:0036211 is a Gene Ontology biological process term describing the covalent alteration of amino acids in proteins, peptides, and nascent polypeptides, including co-translational and post-translational modifications.
What genes are involved in protein modification process?
Key genes include SUMO1, UBC9, SAE1, SAE2, SENP1, OGT, OGA, ZDHHC2, ZDHHC7, APT1, ATG5, ATG12, ATG7, LC3, GPX4, and NCOA4, among many others [1,3,4,5,7].
What are the main types of protein modifications?
Major types include phosphorylation, glycosylation, SUMOylation, palmitoylation, acetylation, methylation, and cysteine-based modifications [2,3,4,7,8].
How does protein modification affect disease?
Dysregulated protein modification contributes to cancer, cardiovascular disease, neurodegeneration, and metabolic disorders by altering protein function and signaling [3,4,7].
What is the role of SUMOylation in cells?
SUMOylation regulates transcription, DNA repair, stress responses, and protein-protein interactions, and is implicated in cancer and neurodegeneration.
How can CRISPR be used to study protein modification?
CRISPR knockout, point mutation, knock-in, and overexpression models allow precise manipulation of modification enzymes and substrates to test their functions in disease pathways [1,5].
What methods are used to detect protein modifications?
Mass spectrometry, western blotting with modification-specific antibodies, immunoprecipitation, click chemistry, and FRET biosensors are commonly used [2,3,4,7,8].
What is the link between protein modification and autophagy?
Autophagy requires the conjugation of ATG12 to ATG5 and LC3 lipidation, both of which are protein modification events.
How does palmitoylation influence apoptosis?
Palmitoylation regulates membrane association and activity of apoptotic proteins, and its dysregulation can affect cell survival.
What is the role of glycosylation in cardiovascular health?
Glycosylation, especially O-GlcNAcylation, modulates cardiac signaling and is linked to diabetic cardiomyopathy and heart failure.
Conclusion
GO:0036211 protein modification process is a broad and essential biological process that governs protein function through covalent alterations. Its dysregulation underlies numerous human diseases, making it a rich area for therapeutic targeting. Advances in CRISPR-based models and proteomic technologies continue to illuminate the complex regulatory networks of protein modifications. EDITGENE provides the tools and expertise to accelerate research in this field, from knockout and knock-in models to library screening and bioinformatics.
References
- 1. Wang Y et al.. 2024. Protein modification and degradation in ferroptosis.. Redox Biol 75:103259 PMID: 38955112
- 2. Lin H et al.. 2018. Introduction: Posttranslational Protein Modification.. Chem Rev 118(3):887-888 PMID: 29439579
- 3. Chang HM et al.. 2020. SUMO: From Bench to Bedside.. Physiol Rev 100(4):1599-1619 PMID: 32666886
- 4. Chatham JC et al.. 2024. Protein glycosylation in cardiovascular health and disease.. Nat Rev Cardiol 21(8):525-544 PMID: 38499867
- 5. Wang R et al.. 2019. Protein Modification and Autophagy Activation.. Adv Exp Med Biol 1206:237-259 PMID: 31776989
- 6. Wu J. 2016. New stories on protein modification.. J Mol Cell Biol 8(1):1 PMID: 26759386
- 7. Li P et al.. 2023. Palmitoylation in apoptosis.. J Cell Physiol 238(8):1641-1650 PMID: 37260091
- 8. Gunnoo SB et al.. 2016. Chemical Protein Modification through Cysteine.. Chembiochem 17(7):529-53 PMID: 26789551
